Peregrine Pharmaceuticals, Inc. - Investor Relations

Investors

Investors

Print

E-mail

Investor Relations

Peregrine Pharmaceuticals, Inc.	Corporate and Media Relations	Investors
14282 Franklin Avenue, Tustin, CA 92780 Phone: 714-508-6000 Fax: 714-838-5817	Linda Donaldson 14282 Franklin Avenue Tustin, CA 92780 Tel: 714-508-6067 Fax: 714-838-5817 pr@peregrineinc.com	GendeLLindheim BioCom Partners, LLC Barbara Lindheim 48 Wall Street, Suite 1100 New York, NY 10005 Tel: 212-918-4949 Tel: 800-987-8256

Featured Events

Nov 16, 2009
Chemical and Biological Defense Science and Technology (CBD S&T) Conference

Oct 22, 2009 at 10:00 AM PT
Annual Shareholders Meeting

Recent Press Releases

Nov 4, 2009
Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies

Nov 3, 2009
Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements

View all releases »

Upcoming Events

Nov 16, 2009
Chemical and Biological Defense Science and Technology (CBD S&T) Conference

View all events & presentations »

Stock Information

NASDAQ:PPHMD
$3.24 + 0.08

Nov 6, 2009
4:00 PM ET

Quotes delayed at least 20 minutes. Information provided by eSignal.

Shareholder Tools

© 2003/2009 Peregrine Pharmaceuticals Inc., All Rights Reserved Disclaimer | Safe Harbor